Genomed S.A.
Genomed S.A. operates in various business sectors.
Market Cap & Net Worth: Genomed S.A. (GEN)
Genomed S.A. (WAR:GEN) has a market capitalization of $70.30K (zł292.31K) as of March 19, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #41774 globally and #392 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genomed S.A.'s stock price zł30.20 by its total outstanding shares 9679 (9.68K).
Genomed S.A. Market Cap History: 2015 to 2026
Genomed S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $43.76K to $70.30K (6.09% CAGR).
Genomed S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genomed S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GEN by Market Capitalization
Companies near Genomed S.A. in the global market cap rankings as of March 19, 2026.
Key companies related to Genomed S.A. by market ranking:
- INVESCO MORTGA.CAP.DL-01 (F:7M20): Ranked #41765 globally with a market cap of $69.09K USD ( €67.31K EUR).
- Digital Power Communications Co. Ltd. (KQ:026890): Ranked #41766 globally with a market cap of $69.09K USD ( ₩101.15 Million KRW).
- JX HOLDINGS (MU:JHJ): Ranked #41775 globally with a market cap of $68.68K USD ( €66.91K EUR).
- Eden Empire Inc (PINK:EDNEF): Ranked #41776 globally with a market cap of $68.59K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #41765 | INVESCO MORTGA.CAP.DL-01 | F:7M20 | $69.09K | €7.04 |
| #41766 | Digital Power Communications Co. Ltd. | KQ:026890 | $69.09K | ₩10150.00 |
| #41775 | JX HOLDINGS | MU:JHJ | $68.68K | €7.25 |
| #41776 | Eden Empire Inc | PINK:EDNEF | $68.59K | $0.00 |
Genomed S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Genomed S.A.'s market cap moved from $43.76K to $ 70.30K, with a yearly change of 6.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł70.30K | +25.83% |
| 2025 | zł55.87K | -9.77% |
| 2024 | zł61.92K | -10.74% |
| 2023 | zł69.37K | -12.35% |
| 2022 | zł79.14K | -0.58% |
| 2021 | zł79.61K | +3.64% |
| 2020 | zł76.82K | +20.44% |
| 2019 | zł63.78K | +7.87% |
| 2018 | zł59.13K | +34.39% |
| 2017 | zł43.99K | -1.25% |
| 2016 | zł44.55K | +1.81% |
| 2015 | zł43.76K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genomed S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.30K USD |
| MoneyControl | $70.30K USD |
| MarketWatch | $70.30K USD |
| marketcap.company | $70.30K USD |
| Reuters | $70.30K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.